---
title: "Shaanxi Lighte released its first-quarter performance, with a net profit attributable to the parent company of 60.8742 million yuan, a year-on-year increase of 39.9%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236990107.md"
description: "Shaanxi Lighte released its Q1 2025 performance report, with operating revenue of 145 million yuan, a year-on-year increase of 27.03%; net profit attributable to the parent company of 60.8742 million yuan, a year-on-year increase of 39.9%; net profit after deducting non-recurring gains and losses of 58.0678 million yuan, a year-on-year increase of 49.78%; basic earnings per share of 0.15 yuan/share"
datetime: "2025-04-22T13:35:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236990107.md)
  - [en](https://longbridge.com/en/news/236990107.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236990107.md)
---

# Shaanxi Lighte released its first-quarter performance, with a net profit attributable to the parent company of 60.8742 million yuan, a year-on-year increase of 39.9%

According to the Zhitong Finance APP, Shaanxi Lighte (688150.SH) released its first quarter report for 2025, with operating revenue of 145 million yuan, a year-on-year increase of 27.03%; net profit attributable to shareholders of the listed company was 60.8742 million yuan, a year-on-year increase of 39.90%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 58.0678 million yuan, a year-on-year increase of 49.78%; basic earnings per share were 0.15 yuan/share

### Related Stocks

- [688150.CN](https://longbridge.com/en/quote/688150.CN.md)

## Related News & Research

- [11:16 ETHaier ist die einzige IoT-Ökosystemmarke der Welt, die acht Jahre in Folge in die Kantar BrandZ Top 100 aufgenommen wurde](https://longbridge.com/en/news/286792596.md)
- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [Trump signs order aimed at preventing illicit financial activity, White House says](https://longbridge.com/en/news/286970478.md)
- [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)